Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Vycor Medical (VYCO) Cash from Financing Activities (2016 - 2025)

Vycor Medical has reported Cash from Financing Activities over the past 16 years, most recently at -$14874.0 for Q4 2025.

  • Quarterly Cash from Financing Activities fell 7.21% to -$14874.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$812.0 through Dec 2025, up 89.25% year-over-year, with the annual reading at -$812.0 for FY2025, 89.25% up from the prior year.
  • Cash from Financing Activities was -$14874.0 for Q4 2025 at Vycor Medical, down from $36957.0 in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $68409.0 in Q1 2022 and troughed at -$19395.0 in Q4 2021.
  • The 5-year median for Cash from Financing Activities is -$7067.0 (2021), against an average of $10984.0.
  • Year-over-year, Cash from Financing Activities surged 293.33% in 2022 and then plummeted 130.31% in 2023.
  • A 5-year view of Cash from Financing Activities shows it stood at -$19395.0 in 2021, then surged by 293.33% to $37497.0 in 2022, then crashed by 130.31% to -$11367.0 in 2023, then dropped by 22.06% to -$13874.0 in 2024, then decreased by 7.21% to -$14874.0 in 2025.
  • Per Business Quant, the three most recent readings for VYCO's Cash from Financing Activities are -$14874.0 (Q4 2025), $36957.0 (Q3 2025), and -$5205.0 (Q2 2025).